The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review
Open accessAbstract
Background: Despite different available methods for colorectal cancer (CRC) screening and their proven benefits, morbidity, and mortality of this malignancy are still high, partly due to low compliance with screening. Minimally invasive tests based on the analysis of blood specimens may overcome this problem. The purpose of this review was to give an overview of published studies on blood markers aimed at the early detection of CRC and to summarize their performance characteristics. Method: The PUBMED database was searched for relevant studies published until June 2006. Only studies with more than 20 cases and more than 20 controls were included. Information on the markers under study, on the underlying study populations, and on performance characteristics was extracted. Special attention was given to performance characteristics by tumor stage. Results: Overall, 93 studies evaluating 70 different markers were included. Most studies were done on protein markers, but DNA markers and RNA markers were also investigated. Performance characteristics varied widely between different markers, but also between different studies using the same marker. Promising results were reported for some novel assays, e.g., assays based on SELDI-TOF MS or MALDI-TOF MS, for some proteins (e.g., soluble CD26 and bone sialoprotein) and also for some genetic assays (e.g., L6 mRNA), but evidence thus far is restricted to single studies with limited sample size and without further external validation. Conclusions: Larger prospective studies using study populations representing a screening population are needed to verify promising results. In addition, future studies should pay increased attention to the potential of detecting precursor lesions. (Cancer Epidemiol Biomarkers Prev 2007;16(10):1935–53)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGEN
Diamandis, E. P., & Yu, H. (1997) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70373-6 · Cited by 172
Cited by
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,525
Cell surface protein glycosylation in cancer
Christiansen, M. N., Chik, J., Lee, L., Anugraham, M., Abrahams, J. L., & Packer, N. H. (2014) · PROTEOMICS · doi:10.1002/pmic.201300387 · Cited by 518
Shen, Q., Fan, J., Yang, X.-R., Tan, Y., Zhao, W., Xu, Y., Wang, N., Niu, Y., Wu, Z., Zhou, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70233-4 · Cited by 394
Colorectal cancer: From prevention to personalized medicine
Binefa, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6786 · Cited by 382
Graham, L. D., Pedersen, S. K., Brown, G. S., Ho, T., Kassir, Z., Moynihan, A. T., Vizgoft, E. K., Dunne, R., Pimlott, L., Young, G. P., et al. (2011) · Genes & Cancer · doi:10.1177/1947601911431081 · Cited by 256
Metadata
- Authors
- Hundt, S., Haug, U., & Brenner, H.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2007-10-01
- Volume
- 16
- Issue
- 10
- Pages
- 1935-1953
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2046673558
- Cited by
- 209
- References
- 2
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review. https://app.cochat.ai/papers/10.1158/1055-9965.epi-06-0994
- The paper
- Hundt, S., Haug, U., & Brenner, H. (2007). Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-06-0994
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.